Double-blind cross-over comparison of indomethacin, flurbiprofen, and placebo in ankylosing spondylitis.
D000082:Acetaminophen / Q000008:administration & dosage; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001713:Biphenyl Compounds / Q000009:adverse effects / Q000627:therapeutic use; D001799:Blood Sedimentation; D002986:Clinical Trials as Topic; D005260:Female; D005461:Fluorine / Q000009:adverse effects / Q000627:therapeutic use; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006261:Headache / Q000139:chemically induced; D006801:Humans; D007213:Indomethacin / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D010146:Pain / Q000188:drug therapy; D010919:Placebos; D011422:Propionates / Q000009:adverse effects / Q000627:therapeutic use*; D013131:Spine / Q000503:physiopathology; D013167:Spondylitis, Ankylosing / Q000188:drug therapy* / Q000503:physiopathology; D013909:Thorax / Q000502:physiology; D014717:Vertigo / Q000139:chemically induced
D000893:Anti-Inflammatory Agents; D001713:Biphenyl Compounds; D010919:Placebos; D011422:Propionates; D005461:Fluorine; D000082:Acetaminophen; D007213:Indomethacin